Jeremy Scott Bredfeldt, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiosurgery | 8 | 2024 | 1330 | 1.280 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 7 | 2025 | 1673 | 0.560 |
Why?
|
Tachycardia, Ventricular | 5 | 2022 | 1313 | 0.520 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2023 | 447 | 0.460 |
Why?
|
Collagen | 3 | 2019 | 2635 | 0.420 |
Why?
|
Cobalt Radioisotopes | 2 | 2021 | 75 | 0.360 |
Why?
|
Whole-Body Irradiation | 2 | 2021 | 438 | 0.330 |
Why?
|
Radiation Oncology | 2 | 2023 | 572 | 0.280 |
Why?
|
Microscopy, Interference | 1 | 2005 | 35 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2329 | 0.230 |
Why?
|
Catheter Ablation | 3 | 2022 | 2787 | 0.220 |
Why?
|
Tattooing | 1 | 2023 | 57 | 0.210 |
Why?
|
Spectrum Analysis, Raman | 1 | 2005 | 250 | 0.210 |
Why?
|
Molecular Biology | 1 | 2005 | 573 | 0.190 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4356 | 0.180 |
Why?
|
Quality Assurance, Health Care | 2 | 2025 | 2171 | 0.180 |
Why?
|
Radiotherapy Dosage | 5 | 2021 | 2916 | 0.180 |
Why?
|
Cardiomyopathies | 2 | 2024 | 2058 | 0.170 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2021 | 798 | 0.170 |
Why?
|
Sarcoidosis | 1 | 2024 | 535 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 36570 | 0.150 |
Why?
|
Automation | 2 | 2023 | 586 | 0.140 |
Why?
|
Syndecan-1 | 1 | 2017 | 163 | 0.140 |
Why?
|
Algorithms | 5 | 2025 | 14073 | 0.130 |
Why?
|
Spinal Neoplasms | 2 | 2025 | 714 | 0.130 |
Why?
|
Heart Conduction System | 1 | 2021 | 1008 | 0.130 |
Why?
|
Phantoms, Imaging | 2 | 2022 | 2474 | 0.130 |
Why?
|
Observer Variation | 1 | 2021 | 2614 | 0.120 |
Why?
|
Electrons | 1 | 2016 | 264 | 0.120 |
Why?
|
Respiration | 1 | 2021 | 1654 | 0.120 |
Why?
|
Image Enhancement | 1 | 2005 | 2858 | 0.110 |
Why?
|
Movement | 1 | 2021 | 1468 | 0.110 |
Why?
|
Health Plan Implementation | 1 | 2016 | 337 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 1567 | 0.110 |
Why?
|
Photons | 1 | 2016 | 591 | 0.100 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5389 | 0.100 |
Why?
|
Anesthesia | 1 | 2023 | 1595 | 0.100 |
Why?
|
Tomography, Optical Coherence | 1 | 2005 | 2954 | 0.090 |
Why?
|
Heart | 2 | 2021 | 4425 | 0.090 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2014 | 496 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2019 | 1730 | 0.090 |
Why?
|
Breast Neoplasms | 2 | 2017 | 21162 | 0.090 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 934 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2022 | 3831 | 0.090 |
Why?
|
Cardiology | 1 | 2021 | 1701 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2023 | 11094 | 0.080 |
Why?
|
Palliative Care | 1 | 2025 | 3640 | 0.080 |
Why?
|
Disease Progression | 2 | 2017 | 13642 | 0.080 |
Why?
|
Quality Control | 2 | 2021 | 834 | 0.070 |
Why?
|
Radiology | 1 | 2021 | 2105 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13489 | 0.070 |
Why?
|
Humans | 25 | 2025 | 766812 | 0.070 |
Why?
|
Neoplasms | 3 | 2021 | 22350 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3384 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2020 | 4306 | 0.060 |
Why?
|
Software | 2 | 2021 | 4464 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3563 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3186 | 0.060 |
Why?
|
Heart Aneurysm | 1 | 2024 | 114 | 0.060 |
Why?
|
Radiometry | 2 | 2019 | 814 | 0.050 |
Why?
|
Radiation Dosage | 2 | 2021 | 1958 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4282 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5367 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2023 | 5306 | 0.050 |
Why?
|
Prospective Studies | 5 | 2025 | 54872 | 0.050 |
Why?
|
Prescriptions | 1 | 2023 | 388 | 0.050 |
Why?
|
Risk Assessment | 1 | 2021 | 24299 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8734 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2005 | 1160 | 0.040 |
Why?
|
Urethra | 1 | 2021 | 406 | 0.040 |
Why?
|
Cattle | 1 | 2005 | 3815 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9407 | 0.040 |
Why?
|
Workflow | 1 | 2023 | 859 | 0.040 |
Why?
|
Health Facilities | 1 | 2023 | 578 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2022 | 772 | 0.040 |
Why?
|
Spine | 1 | 2025 | 1134 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 545 | 0.040 |
Why?
|
Motion | 1 | 2021 | 783 | 0.040 |
Why?
|
Tumor Burden | 1 | 2023 | 1902 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 8928 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4903 | 0.030 |
Why?
|
Particle Accelerators | 1 | 2016 | 172 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2021 | 1788 | 0.030 |
Why?
|
Medical Errors | 1 | 2023 | 1260 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2144 | 0.030 |
Why?
|
Brain | 1 | 2022 | 27158 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5860 | 0.030 |
Why?
|
Fibrillar Collagens | 1 | 2014 | 42 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 139 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2025 | 81657 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1760 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1159 | 0.030 |
Why?
|
Female | 5 | 2025 | 396532 | 0.020 |
Why?
|
Male | 5 | 2025 | 364154 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2017 | 59548 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2021 | 2257 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1251 | 0.020 |
Why?
|
Aged | 3 | 2021 | 171344 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2519 | 0.020 |
Why?
|
Animals | 3 | 2014 | 168939 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 223267 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4968 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14653 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2021 | 3115 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2252 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2020 | 2779 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2017 | 6214 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5873 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2662 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3934 | 0.020 |
Why?
|
Ultrasonography | 1 | 2021 | 5990 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6779 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5618 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6853 | 0.020 |
Why?
|
Mice | 1 | 2014 | 81898 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 65286 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7073 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2025 | 20710 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13476 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14762 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3360 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42577 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7430 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29959 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41706 | 0.010 |
Why?
|
Child | 1 | 2023 | 80670 | 0.010 |
Why?
|
Adult | 1 | 2017 | 223305 | 0.000 |
Why?
|